Nationwide Fund Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Nationwide Fund Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-23,002	Closed	-$241K	–	2210
2017 Q3	$241K	Hold	23,002	–	–	﹤0.01%	2548
2017 Q2	$254K	Sell	23,002 -87,017	-79%	-$811K	﹤0.01%	2528
2017 Q1	$921K	Buy	110,019 +22,331	+25%	+$157K	﹤0.01%	1808
2016 Q4	$609K	Buy	87,688 +62,271	+245%	+$397K	﹤0.01%	2070
2016 Q3	$129K	Hold	25,417	–	–	﹤0.01%	2809
2016 Q2	$152K	Buy	+25,417	New	+$141K	﹤0.01%	2743
2015 Q2	–	Sell	-26,236	Closed	-$77K	–	3359
2015 Q1	$77K	Hold	26,236	–	–	﹤0.01%	3023
2014 Q4	$116K	Hold	26,236	–	–	﹤0.01%	2872
2014 Q3	$135K	Buy	26,236 +435	+2%	+$2.32K	﹤0.01%	2878
2014 Q2	$135K	Buy	+25,801	New	+$112K	﹤0.01%	2925
2013 Q3	–	Sell	-500	Closed	-$1K	–	3284
2013 Q2	$1K	Buy	+500	New	+$1.1K	﹤0.01%	3243

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Nationwide Fund Advisors's ENZ Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2017, closing a stake of 23,002 shares — an estimated $241K sold.

Nationwide Fund Advisors first reported a position in ENZ in Q2 2013 and held it in 11 quarters. The position peaked at $921K in Q1 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

Nationwide Fund Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 23,002 Enzo Biochem, Inc. shares in Q4 2017, an estimated $241K.
Nationwide Fund Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 11 quarters.
Nationwide Fund Advisors's Enzo Biochem, Inc. position peaked at $921K in Q1 2017.
115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.